Value-based pricing 'will not improve' cancer drug access

By Sarah Calkin2012-05-03T00:00:00

Source: Creative images

Government proposals to introduce a value-based pricing system for new drugs will not significantly improve patient access to treatments, experts have warned.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here